Dian Diagnostics Group Co Ltd
SZSE:300244

Watchlist Manager
Dian Diagnostics Group Co Ltd Logo
Dian Diagnostics Group Co Ltd
SZSE:300244
Watchlist
Price: 12.39 CNY -6.49% Market Closed
Market Cap: 7.8B CNY
Have any thoughts about
Dian Diagnostics Group Co Ltd?
Write Note

Dian Diagnostics Group Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dian Diagnostics Group Co Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Dian Diagnostics Group Co Ltd
SZSE:300244
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Gushengtang Holdings Ltd
HKEX:2273
Cash Equivalents
ÂĄ1.3B
CAGR 3-Years
73%
CAGR 5-Years
70%
CAGR 10-Years
N/A
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dian Diagnostics Group Co Ltd
Glance View

Market Cap
7.8B CNY
Industry
Health Care

Dian Diagnostics Group Co. Ltd. engages in the sale, outsourcing, research and development of medical diagnostic product and services. The company is headquartered in Hangzhou, Zhejiang and currently employs 11,123 full-time employees. The company went IPO on 2011-07-19. The firm's main business involves inspection services, product services, health management, judicial expertise, contract research organization (CRO), cold chain logistics and other fields. The firm's business is mainly oriented to medical and health institutions at all levels, such as various general and specialized hospitals, community health service centers, township (town) health centers, physical examination centers, disease prevention and control centers, etc. The firm's products include Atomic Bomb in the field of liquid phase mass spectrometry, Hydrogen Bomb in the field of nucleic acid mass spectrometry, and Man-Made Satellite in the field of pathological diagnosis products and molecular diagnosis products, and others.

Intrinsic Value
25.84 CNY
Undervaluation 52%
Intrinsic Value
Price

See Also

Back to Top